首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Identification of Chinese Herbal Compounds with Potential as JAK3 Inhibitors
【24h】

Identification of Chinese Herbal Compounds with Potential as JAK3 Inhibitors

机译:用作JAK3抑制剂的潜力鉴定中草药化合物

获取原文
           

摘要

The Janus kinases (JAKs) consist of four similar tyrosine kinases and function as key hubs in the signaling pathways that are implicated in both innate and adaptive immunity. Among the four members, JAK3 is probably the more attractive target for treatment of inflammatory diseases because its inhibition demonstrates the greatest immunosuppression and most profound effect in the treatment of such disorders. Although many JAK3 inhibitors are already available, certain shortcomings have been identified, mostly acquired drug resistance or unwanted side effects. To discover and identify new promising lead candidates, in this study, the structure of JAK3 (3LXK) was obtained from the Protein Data Bank and used for simulation modeling and protein-ligand interaction analysis. The ~36,000 Chinese herbal compounds obtained from TCM Database@Taiwan were virtually screened by AutoDock Vina docking program and filtered with Lipinski’s Rules and ADME/T virtual predictions. Because of high occurrence of fake hits during docking, we selected 12 phytochemicals which have demonstrated modulating JAKs expressions among the top 50 chemicals from docking results. To validate whether these compounds are able to directly mediate JAK3 kinase, we have investigated the inhibitory activity using enzymatic activity assays, western blot, and HEK 293 cell STAT5 transactivity assays. The molecular analysis included docking and molecular dynamics (MD) simulations in order to investigate structural conformations and to explore the key amino acids in the interaction between JAK3 kinase and its putative ligands. The results demonstrated that Cryptotanshinone, Icaritin, and Indirubin exhibited substantial inhibitory activity against JAK3 kinase in vitro. The results also provide binding models of the protein-ligand interaction, detailing the interacting amino acid residues at the active ATP-binding domains of JAK3 kinase. In conclusion, our work discovered 3 potential natural inhibitors of JAK3 kinase and could provide new possibilities and stimulate new insights for the treatment of JAK3-targeted diseases.
机译:Janus激酶(Jaks)由四种类似的酪氨酸激酶组成,并用作信号通路中的关键中心,这些途径涉及先天和自适应免疫。在四个成员中,JAK3可能是对炎症性疾病的治疗更具吸引力的目标,因为其抑制证明了对这种疾病的治疗中最大的免疫抑制和最深刻的影响。虽然许多JAK3抑制剂已经可用,但已经确定了某些缺点,主要是获得耐药性或不需要的副作用。为了发现和识别新的有前途的候选人,在本研究中,JAK3(3LXK)的结构是从蛋白质数据库获得的,用于模拟建模和蛋白质 - 配体相互作用分析。从TCM数据库中获得的〜36,000种中草药化合物@台湾实际上是由Autodock Vina对接程序筛选的,并用Lipinski的规则和Adme / T虚拟预测过滤。由于在对接期间出现的假击中率高,我们选择了12种植物化学物质,该植物化学物质已经证明了从对接结果的前50个化学品中的调节jaks表达。为了验证这些化合物是否能够直接介导JAK3激酶,我们已经使用酶活性测定,Western印迹和HEK 293细胞Stat5转移测定研究了抑制活性。分子分析包括对接和分子动力学(MD)模拟,以研究结构构象并探索JAK3激酶与其推定配体之间的相互作用中的关键氨基酸。结果表明,Cryptotanshinone,icaritin和Incirubin在体外对JAK3激酶表现出大量抑制活性。结果还提供了蛋白质 - 配体相互作用的结合模型,详述了JAK3激酶的活性ATP结合结构域的相互作用氨基酸残基。总之,我们的工作发现了jak3激酶的3个潜在的天然抑制剂,可以提供新的可能性,并刺激治疗JAK3靶向疾病的新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号